Brolucizumab

CAS 1531589-02-0Biologic

Overview

Brolucizumab is a monoclonal single-chain variable fragment (scFv) targeting vascular endothelial growth factor A (VEGF-A). It is used in the treatment of neovascular (wet) age-related macular degeneration.

Therapeutic areas

Ophthalmology
Verified Supplier Partner

Do you supply Brolucizumab? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Levofloxacin
24 suppliers
Latanoprost
19 suppliers
Travoprost
13 suppliers
Bimatoprost
12 suppliers
Timolol Maleate
10 suppliers
Brimonidine Tartrate
8 suppliers
Acetazolamide
8 suppliers
Clonidine Hydrochloride
7 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo